Dentsply Sirona Inc. · NASDAQ:XRAY
Dentsply Sirona — J.P. Morgan Healthcare Conference 2024
13 slides from Dentsply Sirona's conference presentation, Jan 9, 2024
Slide 1: J.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 10, 2024
Slide 2: Forward-Looking Statements and Associated Risks
Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits and c
Slide 3: Dentsply Sirona Snapshot
Dentsply Sirona Snapshot (NASDAQ: XRAY) World’s Largest Diversified Manufacturer of Professional Dental Solutions Essential Dental Solutions 36% Connected Technology Solutions 31% Wellspect Healthcare 7% Orthodontic and Implant Solutions 26% United States 35% Europe 40% Rest of World 25% Key Statist
Slide 4: Uniquely Positioned with a Winning Portfolio
4 LSD: Low-Single Digits, MSD: Mid-Single Digits Category data source: internal estimates (1) CAGR through 2026E Uniquely Positioned with a Winning Portfolio Opportunity to Capture Share in Growing Segments Estimated Long-term Market Growth DS Target Growth(1) MSD MSD+ MSD MSD 15%+ 20%+ LSD LSD Tota
Slide 5: Comprehensive End-To-End Portfolio Across Served Markets
Wellspect Healthcare $0.3B 2022 Net Sales Urology Enterology MSD+ Target Growth(1) #2 Continence Care Essential Dental Solutions $1.4B 2022 Net Sales Endodontics Restorative Preventive LSD Target Growth(1) #1 Endodontics #2 Restorative #1 Preventive Orthodontic and Implant Solutions $0.7B 2022 Net S
Slide 6: Our Strategy
Our Strategy Transform oral health and continence care by driving product and service innovation and delivering an exceptional customer and patient experience through an engaged and diverse workforce Enabled by the DS Operating Model ONE TEAM | INNOVATION | DISCIPLINED EXECUTION 6 ACHIEVE ANNUAL GRO
Slide 7: Transforming the Business to Increase Efficiency and Effectiveness
7 … To Increase Efficiency and Effectiveness Strategic Reinvestments for Hygiene and Growth Organizational Realignment $200M+ Est. annual run-rate savings SKU Optimization Channel Investments ERP Clinical Education Transforming the Business … Network Optimization Compliance
Slide 8: Focusing Innovation to Increase Return on Investment
Focusing Innovation … … to Increase Return on Investment Through Meaningful Advancement $180M (~4% of sales) R&D Spend 8 SureSmile Outcome Simulator Patient Canvas Lab Connectivity LoFric Origo Flexible Midwest EnergoExpanded Milling and Printing Materials X-Smart Pro+ Core Capabilities Materials Ex
Slide 9: 3-Year Financial Targets
Key Enablers Organic sales growth in-line or above market Return on growth investments Winning portfolio High-performance culture 3-Year Financial Targets 9 Strategies in Place to Make Meaningful Financial Progress Metric 3-Year Targets Organic Growth CAGR 4% – 6%(1) Adj. EBITDA Margin +500 bps Adj.
Slide 10: Creating Value for Shareholders
Creating Value for Shareholders 10 Clear Strategy and Execution Enabled by the DS Operating Model Well-Positioned in Attractive Industries Disciplined Capital Allocation Roadmap to Accelerate Profitable Growth Largest end-to-end connected portfolio in dental; accretive position in continence care
Slide 11: Appendix
Appendix Dentsply Sy Sirona
Slide 12: Non-GAAP Measures Definitions
Non-GAAP Measures Definitions 12 Organic Sales The Company defines "organic sales" as the reported net sales adjusted for: (1) net sales from acquired businesses recorded prior to the first anniversary of the acquisition; (2) net sales attributable to disposed businesses or discontinued product line
Slide 13: v7
v7
Dentsply Sirona — J.P. Morgan Healthcare Conference 2024 on 6ix